Key result
Smartwatch electrocardiogram monitoring has underreported effectiveness for diagnosing ventricular arrhythmias, despite being tailored for atrial fibrillation diagnosis.
Why the study?
Despite the increasing use of smartwatch single-lead ECG recordings tailored to atrial fibrillation, their effectiveness in diagnosing ventricular arrhythmias remains underreported.
This case report explores the utility and limitations of smartwatch-based single-lead ECG monitoring for diagnosing ventricular arrhythmias.
There is increasing utilization of smartwatch-based cardiac rhythm monitoring. Modern Apple Watches® (Apple Inc., Cupertino, CA) offer a single-lead electrocardiogram (ECG) recording, tailored to atrial fibrillation diagnosis.1–3 Their effectiveness in diagnosing ventricular arrhythmias remains underreported.4,5
No takes yet. Share an insight, caveat, or question.
McIntosh et al. (2025) studied this question. Smartwatch electrocardiogram monitoring has underreported effectiveness for diagnosing ventricular arrhythmias, despite being tailored for atrial fibrillation diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: